MustGrow Announces Market Awareness Services and Investor Relations Agreements

• MustGrow Biologics Corp. entered into two new agreements on May 14, 2026, to enhance market awareness and investor relations visibility in North America and Europe.
• Market One Media Group was engaged for a 12-month term providing editorial and video content via platforms like BNN Bloomberg for a cash fee of $70,000 CAD plus GST. No equity or options were granted.
• GBC AG was contracted for a 24-month market research agreement targeting German and European investors for EUR 40,000 per year in compensation. No equity or options were granted.
• The agreements are effective from January 2026 (Market One) and January 28, 2026 (GBC AG), indicating these costs have been incurred or accrued recently relative to the May announcement.
• This follows a strategic pivot announced in April 2026 where the company closed its NexusBioAg Canadian distribution division to reallocate resources toward TerraSante™ sales in the United States.

• The news is classified as Routine - Positive because it represents expected operational spending on investor relations and marketing, which aligns with the company's growth phase following a recent capital raise.
• There is no material change to the fundamental business model or revenue outlook; this is an expense line item rather than a revenue driver.
• The total cash commitment ($70k CAD + EUR 40k/year) is immaterial relative to the $2 million equity raised in January 2026 and the company's annual burn rate of approximately $7.3 million reported for fiscal year 2025.
• While positive for visibility, it does not alter the risk profile regarding cash runway or product commercialization timelines established in the April 29 earnings release.
• The announcement confirms management is actively seeking to maintain stock liquidity and investor interest post-financing, which is standard procedure but carries no immediate upside catalyst.

• Company: MustGrow Biologics Corp., focused on mustard-derived biocontrol and biofertility products for agriculture.
• Flagship Product (TerraSante™): An organic biofertilizer containing plant proteins and carbohydrates designed to improve soil microbiome health, nutrient efficiency, and crop yields. Currently registered in CA, FL, AZ, ID, OR, WA, and GA.
• Secondary Product (TerraMG™): A mustard-derived biopesticide targeting clubroot disease suppression in canola. Field trials showed up to 95% reduction in resting spores and 19% yield increase in wetter seasons.
• Business Model: Revenue generated through direct sales of TerraSante™ in the U.S. and distribution via NexusBioAg (now closed) for Canadian products.
• Strategic Shift: Management announced closing the NexusBioAg Canadian division in April 2026 to focus capital on U.S. TerraSante™ growth, indicating a consolidation of resources.